Kovai Medical Center & Hospital (KOVAI)₹6,008+0.34%Hospital
In the Jun 2026 quarter (standalone), Kovai Medical Center & Hospital reported sales of ₹431 Cr, up 15.4% from Jun 2025, and net profit of ₹68.82 Cr, up 21.2% year on year. For the year to Mar 2026, sales were ₹1,585 Cr and net profit ₹243 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 303 | 321 | 321 | 315 | 344 | 355 | 357 | 374 | 392 | 407 | 414 | 431 |
| Expenses | 217 | 225 | 229 | 229 | 248 | 252 | 256 | 268 | 285 | 290 | 302 | 307 |
| Operating Profit | 85.06 | 96.15 | 92.14 | 86.14 | 96.06 | 103 | 101 | 106 | 107 | 116 | 111 | 124 |
| OPM % | 28.1% | 30.1% | 29.0% | 27.1% | 28.1% | 29.1% | 28.1% | 28.1% | 27.1% | 28.1% | 27.0% | 29.1% |
| Other Income | 4.02 | 5.02 | 6.02 | 5.02 | 5.02 | 6.02 | 6.02 | 6.03 | 6.02 | 7.03 | 8.02 | 7.02 |
| Interest | 8.04 | 7.03 | 7.03 | 7.03 | 8.04 | 9.04 | 9.04 | 9.03 | 9.04 | 8.04 | 6.03 | 8.03 |
| Depreciation | 22.94 | 22.93 | 23.94 | 23.92 | 23.91 | 24.90 | 24.91 | 25.93 | 26.93 | 27.93 | 28.91 | 31.90 |
| Profit before tax | 58.15 | 71.12 | 67.11 | 61.09 | 67.15 | 75.17 | 74.17 | 76.20 | 78.24 | 87.19 | 84.14 | 92.19 |
| Tax % | 26.0% | 25.0% | 22.0% | 25.0% | 25.0% | 23.0% | 26.0% | 25.0% | 24.0% | 25.0% | 25.0% | 25.0% |
| Net Profit | 42.88 | 52.83 | 51.80 | 45.88 | 50.85 | 57.82 | 54.82 | 56.77 | 58.82 | 64.84 | 62.84 | 68.82 |
| EPS (Rs) | 39.66 | 48.47 | 47.65 | 41.78 | 46.28 | 52.80 | 49.97 | 52.22 | 53.77 | 59.38 | 57.81 | 63.04 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 464 | 531 | 588 | 627 | 712 | 689 | 904 | 1,019 | 1,219 | 1,371 | 1,585 | 1,643 |
| Expenses | 374 | 405 | 459 | 493 | 539 | 495 | 644 | 744 | 873 | 980 | 1,139 | 1,184 |
| Operating Profit | 92.04 | 125 | 129 | 135 | 171 | 195 | 261 | 274 | 347 | 390 | 446 | 459 |
| OPM % | 20.0% | 23.1% | 22.1% | 21.1% | 24.1% | 28.1% | 29.1% | 27.0% | 28.0% | 28.1% | 28.0% | 27.9% |
| Other Income | 8.03 | 6.02 | 7.03 | 8.04 | 10.03 | 12.03 | 12.05 | 14.05 | 21.08 | 21.08 | 26.08 | 28.09 |
| Interest | 17.06 | 15.07 | 13.06 | 15.05 | 18.07 | 33.13 | 46.18 | 43.15 | 37.16 | 36.15 | 36.16 | 31.14 |
| Depreciation | 20.95 | 23.93 | 33.90 | 35.89 | 51.85 | 67.77 | 84.75 | 88.66 | 91.76 | 97.64 | 109 | 116 |
| Profit before tax | 62.15 | 92.21 | 89.20 | 93.16 | 112 | 106 | 141 | 155 | 238 | 279 | 327 | 342 |
| Tax % | 35.0% | 35.0% | 35.0% | 35.0% | 15.0% | 27.0% | 26.0% | 25.0% | 24.0% | 25.0% | 25.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −1.01 | −2.01 | 0.00 | −1.01 | −2.01 | — |
| Net Profit | 39.86 | 59.78 | 57.81 | 59.80 | 94.73 | 77.70 | 104 | 116 | 179 | 208 | 243 | 255 |
| EPS (Rs) | 36.90 | 54.78 | 52.92 | 54.89 | 86.41 | 70.89 | 95.27 | 105.78 | 164.13 | 190.89 | 223.10 | 234.00 |
| Dividend payout % | 7.0% | 5.0% | 6.0% | 5.0% | 3.0% | 4.0% | 6.0% | 8.9% | 6.0% | 5.0% | 7.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.03 | 11.03 | 11.03 | 11.03 | 11.03 | 11.03 | 11.04 | 11.03 | 11.03 | 11.03 | 11.03 | 11.03 |
| Reserves | 127 | 165 | 224 | 276 | 332 | 421 | 499 | 598 | 708 | 877 | 1,075 | 1,308 |
| Borrowings | 163 | 158 | 125 | 202 | 378 | 544 | 624 | 550 | 511 | 310 | 415 | 403 |
| Other Liabilities | 85.41 | 96.46 | 103 | 117 | 130 | 135 | 149 | 185 | 210 | 241 | 300 | 347 |
| Total Liabilities | 386 | 430 | 464 | 605 | 851 | 1,110 | 1,283 | 1,344 | 1,441 | 1,440 | 1,803 | 2,068 |
| Fixed Assets | 282 | 338 | 355 | 444 | 470 | 645 | 1,035 | 1,087 | 1,091 | 1,120 | 1,286 | 1,476 |
| CWIP | 17.04 | 10.03 | 6.02 | 13.03 | 228 | 301 | 45.15 | 5.01 | 23.05 | 39.12 | 154 | 135 |
| Investments | 4.01 | 4.01 | 4.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 |
| Other Assets | 84.63 | 77.71 | 99.58 | 148 | 152 | 164 | 202 | 252 | 327 | 281 | 362 | 457 |
| Inventories | 8.02 | 9.02 | 9.01 | 11.02 | 10.03 | 13.03 | 10.02 | 13.03 | 14.04 | 15.03 | 16.05 | 21.04 |
| Trade receivables | 10.04 | 9.04 | 12.05 | 13.05 | 10.03 | 8.03 | 14.06 | 19.09 | 21.09 | 17.07 | 31.13 | 38.14 |
| Cash & equivalents | 56.03 | 51.02 | 68.06 | 92.12 | 102 | 113 | 155 | 198 | 249 | 211 | 274 | 347 |
| Total Assets | 386 | 430 | 464 | 605 | 851 | 1,110 | 1,283 | 1,344 | 1,441 | 1,440 | 1,803 | 2,068 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 96.71 | 84.69 | 98.59 | 86.68 | 126 | 165 | 185 | 261 | 262 | 343 | 334 | 361 |
| Cash from investing activity | −79.82 | −113 | −82.80 | −192 | −351 | −348 | −180 | −291 | −357 | −289 | −592 | −513 |
| Cash from financing activity | −42.85 | −23.93 | −49.80 | 59.84 | 159 | 113 | 37.87 | −119 | −85.70 | −242 | 61.81 | −57.82 |
| Net cash flow | −26.05 | −53.13 | −33.05 | −45.10 | −66.16 | −70.10 | 44.10 | −149 | −180 | −189 | −197 | −210 |
| Capex | 38.10 | 71.12 | 36.10 | 128 | 278 | 269 | 181 | 99.27 | 127 | 138 | 354 | 253 |
| Free cash flow | 59.97 | 14.01 | 63.02 | −41.03 | −151 | −102 | 4.99 | 163 | 136 | 206 | −17.99 | 111 |
| CFO / OP % | 119.0% | 109.0% | 98.9% | 91.9% | 117.0% | 115.0% | 105.9% | 114.9% | 110.0% | 115.9% | 101.0% | 99.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 10 | 8 | 9 | 9 | 7 | 5 | 8 | 9 | 9 | 6 | 9 | 10 |
| Inventory days | 24 | 21 | 19 | 22 | 19 | 22 | 18 | 18 | 17 | 16 | 14 | 16 |
| Days payable | 52 | 46 | 36 | 42 | 46 | 45 | 28 | 19 | 34 | 29 | 26 | 19 |
| Cash conversion cycle | −20 | −20 | −10 | −13 | −22 | −20 | −3 | 5 | −10 | −8 | −5 | 5 |
| Working capital days | −59 | −55 | −49 | −47 | −54 | −38 | −55 | −48 | −47 | −48 | −56 | −57 |
| ROCE % | 27.1% | 25.1% | 31.1% | 24.0% | 18.1% | 15.1% | 13.1% | 16.0% | 17.1% | 23.1% | 23.1% | 23.0% |
For the Jun 2026 quarter, Kovai Medical Center & Hospital reported sales of ₹431 Cr, up 15.4% year on year and net profit of ₹68.82 Cr, up 21.2% year on year. The operating margin was 29.1%.
Kovai Medical Center & Hospital's sales for the year to Mar 2026 were ₹1,585 Cr; over the last twelve months they were ₹1,643 Cr.
Net profit for the year to Mar 2026 was ₹243 Cr, and ₹255 Cr over the last twelve months. Earnings per share over the same trailing period were ₹234.00.
Kovai Medical Center & Hospital reported borrowings of ₹403 Cr at Mar 2026, against cash and equivalents of ₹347 Cr.
Cash from operations was ₹361 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹111 Cr.